ASSESSMENT OF THE PRACTICAL SIGNIFICANCE OF THE MENOPAUSAL GREEN SCALE (GCS) AS A SCREENING TOOL: A CROSS-SECTIONAL STUDY AMONG POSTMENOPAUSAL WOMEN
Main Article Content
Abstract
The World Health Organization defines «menopause» as the irreversible cessation of menstruation due to the extinction of the follicular function of the ovaries and a decrease in the function of endogenous estrogen.
In the practice of a gynecologist, the menopausal Green scale is not used at outpatient appointments in women's clinics to assess the severity of menopause symptoms.
Many women, entering the period of menopausal changes, consider the manifestation of menopausal symptoms to be quite severe, and hormone therapy is an unacceptable form of treatment for most.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Klinicheskie rekomendacii «Menopauza i klimaktericheskoe sostojanie u zhenshhiny» [Electronic resource] /Associacija ROAG. 2021. Russian (Клинические рекомендации «Менопауза и климактерическое состояние у женщины» [Электронный ресурс] /Ассоциация РОАГ. 2021.) URL: https://roag-portal.ru/recommendations_gynecology (дата обращения: 01.02.2025)
WHO. Menopause [Electronic resource]. 2024. Russian (ВОЗ. Менопауза [Электронный ресурс]. 2024. URL: https://www.who.int/ru/news-room/fact-sheets/detail/menopause (дата обращения: 03.02.2025)
Chuni N, Sreeramareddy CT. Frequency of symptoms, determinants of severe symptoms, validity of and cut-off score for Menopause Rating Scale (MRS) as a screening tool: a cross-sectional survey among midlife Nepalese women. BMC Womens Health. 2011; 11: 30. doi: 10.1186/1472-6874-11-30
Dintakurti N, Kalyanasundaram S, Jha P, Talaulikar V. An online survey and interview of GPs in the UK for assessing their satisfaction regarding the medical training curriculum and NICE guidelines for the management of menopause. Post Reprod Health. 2022; 28(3): 137-141. doi: 10.1177/20533691221106011
Farah D, Ceccaldi PF, Farah L, Ayoubi JM, Vallée A. Willingness to use clinical scales for menopause management among general practitioners. Climacteric. 2024; 27(6): 555-560. doi: 10.1080/13697137.2024.2395986
Souza LACE, Araujo AT, Lima AA. Correlation among four questionnaires that evaluate menopausal symptoms. Menopause. 2022; 29(6): 700-706. doi: 10.1097/GME.0000000000001965
Dvoryanskiy SA, Emelyanova DI, Yagovkina NV. Climacteric syndrome: current status of the issue (Literature review). Medical newsletter of Vyatka. 2017; 1(53): 7-15. Russian (Дворянский С.А., Емельянова Д.И., Яговкина Н.В. Климактерический синдром: современное состояние вопроса //Вятский медицинский вестник. 2017. № 1(53). С. 7-15)
Yarmolinskaya MI, Tatarova NA, Kasyan VN, Petrosyan AS. Efficacy of non-hormonal therapy for menopausal syndrome treatment. Russian Bulletin of Obstetrician-Gynecologist. 2021; 21(2): 91-101. Russian (Ярмолинская М.И., Татарова Н.А., Касян В.Н., Петросян А.С. Эффективность негормональной терапии в лечении женщин с климактерическим синдромом //Российский вестник акушера-гинеколога. 2021. Т. 21, № 2. 91-101.) doi: 10.17116/rosakush20212102191
Borzu ZA, Karimy M, Leitão M, Pimenta F, Albergaria R, Khoshnazar Z, et al. Validation of the menopause representation questionnaire (MenoSentations-Q) among Iranian women and cross-cultural comparison with Portuguese women. BMC Womens Health. 2025; 25(1): 87. doi: 10.1186/s12905-025-03606-5
Sourouni M, Zangger M, Honermann L, Foth D, Stute P. Assessment of the climacteric syndrome: a narrative review. Arch Gynecol Obstet. 2021; 304(4): 855-862. doi: 10.1007/s00404-021-06139-y
Wang L, Zhang R, Yang Y, Sun XY, Zhang BaoLi, Zhu HaiYing, et al. Severity and factors of menopausal symptoms in middle-aged women in Gansu Province of China: a cross-sectional study. BMC Women's Health. 2021; (21): 405. doi: 10.1186/s12905-021-01531-x